Trillium Therapeutics Inc. EPS - Earnings per Share 2014-2021 | TRIL
Trillium Therapeutics Inc. eps - earnings per share from 2014 to 2021. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Trillium Therapeutics Inc. Annual EPS |
| 2020 |
$-0.70 |
| 2019 |
$-1.15 |
| 2018 |
$-2.35 |
| 2017 |
$-3.56 |
| 2016 |
$-3.07 |
| 2015 |
$-1.74 |
| 2014 |
$-2.77 |
| 2013 |
$-0.11 |
| 2012 |
$-0.06 |
| Trillium Therapeutics Inc. Quarterly EPS |
| 2021-09-30 |
$-0.18 |
| 2021-06-30 |
$-0.18 |
| 2021-03-31 |
$-0.11 |
| 2020-12-31 |
$-0.03 |
| 2020-09-30 |
$-0.14 |
| 2020-06-30 |
$-0.28 |
| 2020-03-31 |
$-0.25 |
| 2019-12-31 |
$-0.17 |
| 2019-09-30 |
$-0.34 |
| 2019-06-30 |
$-0.18 |
| 2019-03-31 |
$-0.46 |
| 2018-12-31 |
$-0.43 |
| 2018-09-30 |
$-0.70 |
| 2018-06-30 |
$-0.71 |
| 2018-03-31 |
$-0.51 |
| 2017-12-31 |
$-0.63 |
| 2017-09-30 |
$-0.84 |
| 2017-06-30 |
$-0.99 |
| 2017-03-31 |
$-1.10 |
| 2016-12-31 |
$-0.87 |
| 2016-09-30 |
$-0.78 |
| 2016-06-30 |
$-0.75 |
| 2016-03-31 |
$-0.67 |
| 2015-12-31 |
$-0.14 |
| 2015-09-30 |
$-0.16 |
| 2015-06-30 |
$-0.65 |
| 2015-03-31 |
$-0.79 |
| 2014-12-31 |
$-2.71 |
| 2014-09-30 |
$-0.02 |
| 2014-06-30 |
$-0.03 |
| 2014-03-31 |
$-0.02 |
| 2013-12-31 |
$-0.03 |
| 2013-09-30 |
$-0.03 |
| 2013-06-30 |
$-0.03 |
| 2013-03-31 |
$-0.02 |
